Caige Li

Hebei Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index224citations19works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hippo pathway signaling and YAP/TAZ(7), Lipid metabolism and biosynthesis(4), Cancer Immunotherapy and Biomarkers(2), Liver Disease Diagnosis and Treatment(2), Autophagy in Disease and Therapy(2)

Publications19 total

Efficacy and safety of needle-free injection in patients with type 2 diabetes mellitus undergoing intensive insulin therapy: a randomized controlled trial based on the flash glucose monitoring system
Frontiers in Endocrinology·2026Open Access
A Review of the Therapeutic Potential of Ginseng and Its Bioactive Components in Nonalcoholic Fatty Liver Disease
Drug Design Development and Therapy·2025· 7 citedOpen Access
Hepatocyte-Specific Yap1 Knockout Maintained the Liver Homeostasis of Lipid Metabolism in Mice
Diabetes Metabolic Syndrome and Obesity·2024· 2 citedOpen Access
Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy
Frontiers of Medicine·2023· 18 cited
Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction–associated fatty liver disease
Journal of Ethnopharmacology·2023· 18 cited
Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting <scp>YAP1</scp> expression to enhance <scp>anti‐PD</scp>‐1 efficacy
Phytotherapy Research·2022· 29 cited
Wolfberry enhanced the abundance of <i>Akkermansia muciniphila</i> by <scp>YAP1</scp> in mice with acetaminophen‐induced liver injury
The FASEB Journal·2022· 7 cited
Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma
Journal of Natural Medicines·2022· 25 cited
The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells
Evidence-based Complementary and Alternative Medicine·2022· 4 citedOpen Access
Dihydroartemisinin promoted FXR expression independent of YAP1 in hepatocellular carcinoma
The FASEB Journal·2022· 25 cited
Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma
Phytomedicine·2021· 33 cited
miRNA-576 Alleviates the Malignant Progression of Atherosclerosis through Downregulating KLF5
Disease Markers·2021· 12 citedOpen Access
Dihydroartemisinin broke immune evasion through YAP1/JAK1/STAT1, 3 pathways to enhance anti-PD-1 therapy in hepatocellular carcinoma
2021Open Access
Cisplatin Increased the Expression of PD-1 and PD-L1 by YAP1 in Hepatocellular Carcinoma
Research Square (Research Square)·2021Open Access
Liraglutide, a glucagon‑like peptide‑1 analog, inhibits high glucose‑induced oxidative stress and apoptosis in neonatal rat cardiomyocytes
Experimental and Therapeutic Medicine·2019· 25 citedOpen Access
Effect of revolvin D1 on TLR4 in skeletal muscle of type 2 diabetic mice
Zhongguo yishi zazhi·2018
Prophylactic Use of Troxerutin Can Delay the Development of Diabetic Cognitive Dysfunction and Improve the Expression of Nrf2 in the Hippocampus on STZ Diabetic Rats
Behavioural Neurology·2018· 19 citedOpen Access
Impact of self-management support on the behavior and metabolic parameters of type 2 diabetic patients with obesity
Zhonghua xiandai huli zazhi·2016
Effects of Small Dose of Amlodipine Combined with Compound Amiloride or Telmisartan on Insulin Resistance in Patients with Primary Hypertension
Zhongguo yaofang·2011

Frequent Co-authors

Jingmin Ji(11), Xinli Shi(11), Liyuan Hao(9), Yinglin Guo(8), Qing Peng(7), Yu Xue(7), Zhiqin Zhang(6), Yiwei Liu(5), Junlan Lu(5), Kangning Zheng(4), Shenghao Li(3), Yuting Gao(3), Lihui Zhang(3), Yiwei Liu(3), Zhiqin Zhang(3), Zhiqin Zhang(2), Yi-Wei Liu(2), Yu Xue(2), Yi Gong(2), Yuman Zhang(2)